NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

Abstract Background Luminal A tumours generally have a favourable prognosis but possess the highest 10‐year recurrence risk among breast cancers. Additionally, a quarter of the recurrence cases occur within 5 years post‐diagnosis. Identifying such patients is crucial as long‐term relapsers could ben...

Full description

Bibliographic Details
Main Authors: Marina Mendiburu‐Eliçabe, Natalia García‐Sancha, Roberto Corchado‐Cobos, Angélica Martínez‐López, Hang Chang, Jian Hua Mao, Adrián Blanco‐Gómez, Ana García‐Casas, Andrés Castellanos‐Martín, Nélida Salvador, Alejandro Jiménez‐Navas, Manuel Jesús Pérez‐Baena, Manuel Adolfo Sánchez‐Martín, María Del Mar Abad‐Hernández, Sofía Del Carmen, Juncal Claros‐Ampuero, Juan Jesús Cruz‐Hernández, César Augusto Rodríguez‐Sánchez, María Begoña García‐Cenador, Francisco Javier García‐Criado, Rodrigo Santamaría Vicente, Sonia Castillo‐Lluva, Jesús Pérez‐Losada
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Clinical and Translational Medicine
Subjects:
breast cancer
genetic signature
LASSO
luminal A subtype
NCAPH
prognosis
Online Access:https://doi.org/10.1002/ctm2.1554

Similar Items

Similar Items